Banco Santander S.A. (SAN) |
|
4.05 0.16 (4.11%)
|
12-12 16:02 |
|
Open: |
3.99 |
Pre. Close: |
3.89 |
|
High:
|
4.07 |
Low:
|
3.97 |
|
Volume:
|
11,587,929 |
Market Cap:
|
68349M |
|
|
|
|
Banco Santander SA is a global bank engaged in retail banking. The firm also offers other services such as wholesale banking, insurance and asset management. Its business operations are spread across Latin America, Continental Europe, and the U.S. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.923 - 3.941 |
3.941 - 3.959 |
|
Low:
|
3.841 - 3.863 |
3.863 - 3.884 |
|
Close:
|
3.855 - 3.888 |
3.888 - 3.92 |
|
Technical analysis |
as of: 2019-12-12 4:03:56 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 4.93 One year: 5.76 |
| Support: |
Support1: 3.94 Support2: 3.77 |
| Resistance: |
Resistance1: 4.22 Resistance2: 4.93 |
| Pivot: |
3.91 |
| Moving Average: |
MA(5): 3.93 MA(20): 3.90
MA(100): 4.01  MA(250): 4.42 |
| MACD: |
MACD(12,26): -0.03 Signal(9): -0.05 |
| Stochastic oscillator: |
%K(14,3): 67.07 %D(3): 62.76 |
| RSI: |
RSI(14): 57.83 |
| 52-week: |
High: 5.25 Low: 3.65 Change(%): -10.6 |
| Average Vol(K): |
3-Month: 860109 10-Days: 772106 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.SAN has closed above the upper band by 11.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 47.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to SAN's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2019-12-12
Global Osteoarthritis Therapeutics Market 2019-2023 | Evolving Opportunities With Bayer AG and Sanofi | Technavio
LONDON--(BUSINESS WIRE)-- #Biotechnology--Global osteoarthritis therapeutics market is poised to grow by USD 2.56 billion during 2019-2023 at a CAGR of about 8% during the forecast period.
2019-12-12
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
